Their results suggest that a combination of COL5A1 and COL1A1 mutations may lead to compound phenotypes of OI and EDS, while COL1A1 (c.2010delT) may result in OI. The gene discussed is COL5A1; the disease is Ehlers-Danlos syndrome.